Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view

Background Since December 2019, the newly emerged SARS-CoV-2 virus continues to infect humans and many people died from severe Covid-19 during the last 2 years worldwide. Different approaches are being used for treatment of this infection and its consequences, but limited results have been achieved...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. General subjects Vol. 1865; no. 11; p. 129974
Main Authors Najmeddin, Ali, Bahrololoumi Shapourabadi, Mina, Behdani, Mahdi, Dorkoosh, Farid
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.11.2021
Published by Elsevier B.V
Subjects
Online AccessGet full text

Cover

Loading…